1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. PDL BioPharma Inc (PDLI)
  7. Quote

PDLI PDLI

PDL BioPharma Stock Price

2.47
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
2.47
Volume 0
Bid Price 2.62
Ask Price 2.63
News -
Day High

Low
2.39

52 Week Range

High
2.84

Day Low
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
PDL BioPharma Inc PDLI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 2.47 19:00:00
Open Price Low Price High Price Close Price Prev Close
2.47 2.47
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 2.47 USD

Period:

Draw Mode:

PDL BioPharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 282.85M 114.52M 110.44M $ 54.70M $ - - -1.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

PDL BioPharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PDLI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year2.562.842.392.554,400,595-0.09-3.52%
3 Years3.023.892.062.981,391,047-0.55-18.21%
5 Years2.543.891.932.781,518,554-0.07-2.76%

PDL BioPharma Description

PDL BioPharma Inc acquires and manages a portfolio of companies, products, royalty agreements and debt facilities in the biotech, pharmaceutical and medical device industries. The operating segments of the company are Medical Devices, Strategic Positions, Pharmaceutical and Income Generating Assets, of which key revenue is derived from the Pharmaceutical segment. The Pharmaceutical segment consists of revenue derived from branded prescription medicine products sold under the name Tekturna and Tekturna HCT in the U.S, and Rasilez and Rasilez HCT in the rest of the world (collectively, the Noden Products). Geographically, the company operates in Europe, North America, Asia and Other countries, of which prime revenue is generated from Asia and North America.


Your Recent History
NASDAQ
PDLI
PDL BioPha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.